The global inflation devices market was valued at USD 619.02 million in 2025 and is projected to grow from USD 652.15 million in 2026 to USD 989.69 million by 2034, registering a CAGR of 5.35% during the forecast period (2026–2034). The market is witnessing steady growth due to the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and continuous advancements in interventional cardiology technologies. Growing demand for precision balloon inflation devices in angioplasty and other catheter-based procedures is further supporting market expansion.

Key Highlights

• The global inflation devices market was valued at USD 619.02 million in 2025.

• The market is projected to reach USD 989.69 million by 2034.

• The market is expected to grow at a CAGR of 5.35% during the forecast period (2026–2034).

• North America is the largest regional market.

• Asia-Pacific is the fastest-growing regional market.

• By Product Type, the Analog Inflation Devices segment holds the largest market share.

• By Application, the Coronary Angioplasty segment is the largest application segment.

• By End User, the Hospitals segment dominates the market and is expected to remain the fastest-growing end-user segment.

Market Dynamics

Driver

Rising Prevalence of Cardiovascular Diseases and Growth of Minimally Invasive Procedures

The increasing global burden of cardiovascular diseases (CVDs), including coronary artery disease and peripheral artery disease, continues to drive the demand for inflation devices. These devices are widely used during balloon angioplasty procedures to precisely control balloon pressure, enabling safe and effective dilation of narrowed blood vessels. As the incidence of lifestyle-related diseases continues to rise, healthcare providers are increasingly adopting minimally invasive treatment approaches that improve patient outcomes and reduce recovery time.

Additionally, technological advancements in interventional cardiology have led to the development of highly accurate inflation devices with improved pressure control, ergonomic designs, and enhanced safety features. Increasing healthcare expenditure and expanding access to advanced cardiac care are further contributing to market growth.

Restraint

High Cost of Interventional Procedures and Product Recall Risks

Despite increasing adoption, the high cost associated with interventional cardiovascular procedures and specialized medical devices remains a challenge, particularly in developing economies with limited healthcare budgets. Reimbursement limitations in certain regions may also restrict patient access to advanced treatment options.

Furthermore, stringent regulatory requirements, product approval timelines, and occasional product recalls due to manufacturing defects or quality concerns may affect market expansion. Healthcare providers continue to demand devices that meet rigorous safety and performance standards while maintaining cost efficiency.

Opportunity

Technological Innovations and Expanding Healthcare Infrastructure

Continuous innovation in inflation device technology is creating significant growth opportunities for market participants. Manufacturers are introducing digital inflation devices with enhanced pressure monitoring capabilities, greater accuracy, and user-friendly interfaces to improve procedural efficiency and patient safety.

Moreover, the expansion of catheterization laboratories, increasing investments in healthcare infrastructure, and the growing adoption of minimally invasive procedures across emerging economies are expected to create substantial opportunities. Rising awareness regarding early diagnosis and treatment of cardiovascular diseases will further support long-term market growth.

Top Market Players

• Boston Scientific Corporation

• Merit Medical Systems, Inc.

• B. Braun Melsungen AG

• Medtronic plc

• Terumo Corporation

• Cardinal Health, Inc.

• Cook Medical

• Teleflex Incorporated

• Abbott Laboratories

• Becton, Dickinson and Company (BD)

• Acclarent, Inc.

• QXMedical LLC

• SCW Medicath Ltd.

• Zhejiang Kindly Medical Devices Co., Ltd.

• Lepu Medical Technology (Beijing) Co., Ltd.

Market Segmentation

By Product Type

• Analog Inflation Devices

• Digital Inflation Devices

By Application

• Coronary Angioplasty

• Peripheral Angioplasty

• Endovascular Procedures

• Urology

• Gastroenterology

• Others

By End User

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

• Catheterization Laboratories

By Region

North America

• United States

• Canada

• Mexico

Europe

• Germany

• United Kingdom

• France

• Italy

• Spain

• Rest of Europe

Asia-Pacific

• China

• Japan

• India

• South Korea

• Australia

• Rest of Asia-Pacific

Latin America

• Brazil

• Argentina

• Rest of Latin America

Middle East & Africa

• GCC

• South Africa

• Rest of Middle East & Africa

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/inflation-devices-market

Gain access to comprehensive market intelligence featuring detailed market forecasts, competitive benchmarking, company profiles, regional analysis, technology trends, regulatory developments, investment opportunities, product innovations, and strategic recommendations to support informed business decisions and sustainable growth.

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Contact Us

Email: [email protected]

Tel:

• +1 646 905 0080 (U.S.)

• +44 203 695 0070 (U.K.)